APOTEX, INC. v. CEPHALON, INC. et al
Filing
812
MEMORANDUM OPINION ORDER THAT DEFENDANTS' JOINT MOTION TO EXCLUDE TESTIMONY OF PLAINTIFF APOTEX, INC.'S FED. R. EVID. 701 WITNESS, GORDON FAHNER (DOC. NO. #683 ), IS GRANTED. SIGNED BY MAGISTRATE JUDGE DAVID R. STRAWBRIDGE ON 10/1/2014. 10/2/2014 ENTERED AND COPIES MAILED AND E-MAILED.(amas)
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
APOTEX, INC.
v.
CEPHALON, INC., et al.
:
:
:
:
:
CIVIL ACTION
NO. 2:06-cv-2768
ORDER
AND NOW this 1st day of October, 2014, for the reasons set forth in the attached
Memorandum Opinion, it is hereby ORDERED that Defendants’ Joint Motion to Exclude
Testimony of Plaintiff Apotex, Inc.’s Fed. R. Evid. 701 Witness, Gordon Fahner (Doc. 683),
filed by Cephalon, Inc., Barr Laboratories, Inc., Mylan, Inc., Mylan Pharmaceuticals, Inc.,
Ranbaxy Laboratories, Ltd., Ranbaxy Pharmaceuticals, Inc., Teva Pharmaceutical Industries,
Limited and Teva Pharmaceuticals USA, Inc. is GRANTED.
BY THE COURT:
/s/ David R. Strawbridge
DAVID R. STRAWBRIDGE
United States Magistrate Judge
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?